The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Scientists report landmark "evolutionary double-bind" strategy to overcome treatment resistance in prostate cancer.

Thousands of men with prostate cancer are set to get a life-extending drug on the NHS within weeks – in a breakthrough that could give families precious extra years together. For the first time, ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, talazoparib, which has been approved for NHS use. The once-daily pill, with its ...

Briton with cancer operated on by doctor located 1,500 miles away using four-armed robot fitted with 3D camera ...

The Prostate Cancer Foundation (PCF) today announced a $10 million unrestricted gift from an anonymous donor to launch a TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Award, which will ...

The Prostate Cancer Foundation (PCF) today announced $6.3 million in funding for 31 exceptional Young Investigators pursuing ...

A prostate cancer committee has been accused of exaggerating the risks of screening. Advisers to Wes Streeting, the Health ...

Add Yahoo as a preferred source to see more of our stories on Google. The once-daily pill, with its brand name Talzenna and produced by Pfizer, offers a crucial at-home treatment option after ...